In addition, Studies have shown that the combination of ICG-1 and anti-PD-1 antibody can promote the infiltration of DCs and CD8+ T cells within the TME, thereby enhancing immune cell activity and inhibiting tumor growth. Here, CD8A is linked to neoplasm.